Market View

The U.S. market remains in a Confirmed Uptrend. Indices pulled back over the last few sessions after accelerating higher earlier in the week. The S&P 500 is testing its 10-DMA (4,519) followed by the next level of support at its 200-DMA (4,485). The Nasdaq is also slightly above 10-DMA (14,137) support but remains below 200-DMA resistance despite the advance over the last few weeks. The distribution day count stands at one on the S&P 500 and none on the Nasdaq.

Defensive sectors – Utility, Consumer Staples and Health Care – along with Consumer Cyclical, led by Autos Manufacturers, outperformed this week after rising 1-3% respectively. Conversely, three sectors declined more than 1% led lower by Transportation (-4%), and Energy (-2%). Multiple sectors continue to trade below 200-DMA resistance including Financial, Technology, Retail , Consumer Cyclical and Health Care. The best performing industry groups over the past week include Consumer Electronics, Autos, Airlines, Travel Booking, Utilities, Outpatient Care, Medical Products, Medical Software, Desktop Software, Pollution Control, and REITs. The worst performing groups include Wholesale Autos, Drug Stores, Trucks, Mobile Homes, Home Builders, Building Products, Household Appliances, Toys, Commercial Loans, and Banks. 62% of S&P 500 stocks are trading above their 50-DMA and 51% are trading above their 200-DMA, compared with 60% and 51%, respectively, a week ago. 55% of Nasdaq 100 stocks are trading above their respective 50- DMA, compared with 59% one week ago.

Won Global View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq cleared above February highs yesterday, continuing to press higher with no distribution. The S&P 500 is now just 4% off all-time high resistance (4,818), while the Nasdaq is now 10% off highs and just below resistance at its 200-DMA (14,727).

O’Neil Capital Equipment Sector Weekly

Vulcan Materials Co (VMC; $26B market cap; $152M ADV) is the largest manufacturer and supplier of construction aggregates in the U.S. The aggregates segment, which produces and sells crushed stone, sand, and
gravel, generates three-fourths of the company’s revenue. The company also produces aggregates-based construction materials, including asphalt and ready-mixed concrete (one-fourth of revenue). Its materials are used to
build and maintain infrastructure such as highways, railroads, bridges, airport runways, and other large projects, with ~43% of its shipments used in publicly funded civil construction projects. Private-sector residential and
non-residential construction accounted for the rest of its aggregates shipments. VMC should benefit from the increased investment in improving public infrastructure and increasing demand for single-family housing in the
U.S. The stock is forming the right side of a stage-one six-week flat base and testing support near its 50-DMA. It should turn actionable if it bounces off its 50-DMA and breaks out of pivot at $210.16 (+5%).

Global Laggards

This report has been curated by our sector analysts to find stocks showing technical weakness. We believe these stocks are laggards relative to their own domestic markets. We recommend that they be underweighted as they may be vulnerable to further downside risk and underperformance.

Stocks worth focusing on in this week’s Global Laggards:

U.S.

Jack in the Box ( JACK ) – Retail ( $2.7B market cap ) – Operates and franchises Jack in the Box quick service restaurants in the United States.

*   Shares are finding resistance at the 21-EMA and are currently testing support along ~$91. We believe the stock will eventually break support and follow the RS line lower toward the low $80s.
*   The stock’s RS line is near multi-year lows. It has a weak RS Rating of 13 and A/D Rating of D+.
*   Fund sponsorship has been steadily declining since peaking in the September 2016 quarter.
*   The Company recently gave FY 2018 guidance that fell short of street expectations. The Company expects EBITDA of $260M-270M (versus street of $288M). Part of the reason for the weak EBITDA was contractual obligations to support services for Qdoba as part of the spinoff sale to Apollo Global Management.
*   The Company missed consensus EPS expectations in three of the past four quarters.

Developed

Hoya ( HQ@N.JP; 7741:JP) – Health Care ($19.4B market cap) – Hoya is a global supplier of eyeglasses, medical endoscopes, intraocular lenses, optical lenses, and key components for semiconductor devices, LCD panels, and HDDs.

*   The stock is breaking back below its 50- and 200-DMA on heavy volume.
*   The stock’s RS line is hitting YTD lows with an RS Rating of 11 and an A/D Rating of D.
*   The Company released Q3 FY 2018 results, below expectations due to lower-than-expected profit from the Company’s life care segment. Operating profit of ¥33.2B fell short of the ¥34.2B consensus estimate. Sales of eyeglass lenses in Europe and Japan were weak and sales of endoscopes in Europe were weaker than expected. Hoya announced new full-year pretax profit guidance of ¥128B, below consensus of ¥130.2B.